Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Boston Scientific has received FDA approval for Latitude 6.0, a software upgrade to the company's Latitude Patient Management system. The upgrade allows to view an expanded history of a patient's remote follow-up data.
Subscribe to our email newsletter
Boston Scientific Latitude Patient Management system can detect changes in a patient’s heart health status between scheduled follow-up visits and send relevant data and alerts directly to physicians. More than 160,000 patients have been enrolled on the system at more than 2,300 clinics across the US.
Boston Scientific said that the Latitude system is available in 15 other countries and use of the system continues to expand internationally with nearly 1,700 patients enrolled in Europe at approximately 150 clinics.
Kenneth Stein, chief medical officer of CRM for cardiology, rhythm and vascular group at Boston Scientific, said: Remote monitoring between regularly scheduled follow-up visits allows earlier observation of events, giving physicians the option to intervene earlier. We welcome FDA approval of Latitude 6.0, which offers software improvements in response to physician feedback.